Merck & Co in pole position for Ebola vaccine approval as FD...

The FDA is to review Merck & Co’s Ebola vaccine, giving the US pharma a chance to grab a first approval within six months.

First effective Ebola treatment a step closer after breakthr...

Clinical trials of four experimental treatments for Ebola in the Congo have been halted early after two of the drugs showed compelling benefits in a breakthrough against the deadly virus.

GSK exits Ebola vaccine R&D as J&J rival starts Uganda trial

Merck & Co begins US filing of Ebola vaccine

Merck & Co has begun a rolling filing in the US of its Ebola Zaire vaccine, known as V920, after the FDA said it could represent a breakthrough in treatment.

IBM Watson creates macromolecule to help fight Ebola, Zika

IBM Watson has helped to develop a 'triple-play action' macromolecule that could help fight both viral infection and drug resistance.